Erythrodermic presentation of psoriasis in a patient treated with dupilumab
Sign Up to like & getrecommendations! Published in 2018 at "JAAD Case Reports"
DOI: 10.1016/j.jdcr.2018.05.014
Abstract: IL: interleukin Th: T-helper D upilumab is an interleukin (IL)-4 receptor a (IL-4Ra) antagonist that inhibits IL-4 and IL13 signaling, keymediators of T-helper (Th) 2-mediated inflammation. Whereas an immune shift toward Th2 drives atopic dermatitis… read more here.
Keywords: erythrodermic presentation; patient treated; treated dupilumab; psoriasis patient ... See more keywords
Hailey–Hailey disease treated with dupilumab: a case series
Sign Up to like & getrecommendations! Published in 2021 at "British Journal of Dermatology"
DOI: 10.1111/bjd.20475
Abstract: Hailey-Hailey disease (HHD), also known as familial benign chronic pemphigus, is an autosomal dominant genetic blistering disease caused by a mutation in a calcium transporter protein in the Golgi apparatus encoded by the ATP2C1 gene on… read more here.
Keywords: disease treated; treated dupilumab; disease; hailey disease ... See more keywords
Facial erythema in patients with atopic dermatitis treated with Dupilumab – a descriptive study of morphology and Aetiology
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.18327
Abstract: The development of dermatitis on face and neck, which was not described in phase 3 clinical trials, has been reported in the literature in patients treated with dupilumab. Little is known regarding the causes or… read more here.
Keywords: treated dupilumab; erythema patients; atopic dermatitis; dermatitis ... See more keywords
Reply to: ‘Severe bullous pemphigoid following Covid‐19 vaccination resistant to rituximab and successfully treated with dupilumab’ by Baffa et al.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.18893
Abstract: Dear Editor, We read with interest the article by Baffa et al., who reported a case of severe bullous pemphigoid (BP) developed 10 days after the second dose of Pfizer/BioNtech BNT162b2 mRNA vaccine against Covid19,… read more here.
Keywords: rituximab successfully; bullous pemphigoid; treated dupilumab; severe bullous ... See more keywords
Hyperthyroidism in a 15-year-old adolescent treated with Dupilumab for severe allergic asthma and atopic dermatitis.
Sign Up to like & getrecommendations! Published in 2023 at "Allergologia et immunopathologia"
DOI: 10.15586/aei.v51i3.786
Abstract: Dupilumab is a biologic, acting on IL-4 and IL-13 pathways. Dupilumab has a pediatric indication for treating severe asthma and atopic dermatitis. We report a pediatric case concerning paucisymptomatic, transient, and self-resolving hyperthyroidism. The updated… read more here.
Keywords: atopic dermatitis; hyperthyroidism; asthma atopic; treated dupilumab ... See more keywords
Measuring Nasal Patency and the Sense of Smell in CRSwNP Patients Treated with Dupilumab
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm13020234
Abstract: Chronic rhinosinusitis with nasal polyps (CRSwNP) in the most severe forms is associated with a poor quality of life. Dupilumab has been suggested as an add-on treatment option for severe CRSwNP. Severe CRSwNP patients treated… read more here.
Keywords: crswnp patients; treated dupilumab; smell; patients treated ... See more keywords